Cleared Traditional

SATELLITE K+ BLOOD POTASSIUM MONITORING SYSTEM (K897110) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K897110 · Medisense, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1990
Decision
63d
Days
Class 2
Risk

K897110 is an FDA 510(k) clearance for the SATELLITE K+ BLOOD POTASSIUM MONITORING SYSTEM. Classified as Electrode, Ion Specific, Potassium (product code CEM), Class II - Special Controls.

Submitted by Medisense, Inc. (Cambridge, US). The FDA issued a Cleared decision on February 27, 1990 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1600 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medisense, Inc. devices

Submission Details

510(k) Number K897110 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 1989
Decision Date February 27, 1990
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 88d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEM Electrode, Ion Specific, Potassium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEM Electrode, Ion Specific, Potassium

All 88
Devices cleared under the same product code (CEM) and FDA review panel - the closest regulatory comparables to K897110.
ISE indirect K for Gen.2
K253491 · Roche Diagnostics · Feb 2026
ABL90 FLEX PLUS System
K241037 · Radiometer Medicals Aps · Jan 2025
EasyStat 300
K220396 · Medica Corporation · Sep 2023
ISE Electrodes
K230890 · Randox Laboratories, Ltd. · Sep 2023
SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+
K200544 · Diamond Diagnostics, Inc. · Oct 2020
GEM PREMIER 4000
K112995 · Instrumentation Laboratory CO · May 2012